2BB score and signals
Voyager Therapeutics, Inc.’s current 2BB score is 15 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 16 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 47 | Moderate |
Company facts
| Headquarters | Lexington, Massachusetts, United States |
| Founded | 2013 |
| Employees | 141 |
| 52-week range | $1.98 – $5.55 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-08 | — | -0.4104 | — | $8.88M |
| 2026-11-08 | — | -0.4277 | — | $6.48M |
| 2026-07-30 | — | -0.4939 | — | $4.82M |
| 2026-05-07 | -0.47 | -0.5622 | $2.59M | $8.96M |
Related companies
2BBBullish & Bearish